首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1559497

2024-2029 年全球組織診斷產業的成長機會

Growth Opportunities in the Tissue Diagnostics Industry, Global, 2024-2029

出版日期: 2024年08月26日 | 出版商:

Frost & Sullivan | 英文 84 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

專門用於伴同性診斷的先進染色和多組體學功能將推動市場成長

由於個人化醫療中需要先進的染色來準確識別生物標記、組織切片檢查的檢測量以及預分析和先進染色平台的開發，預計全球組織診斷市場將顯著成長。

據世界衛生組織稱，到 2040 年，全球癌症病例預計將增加 60%，從而推動對組織診斷的需求。這一成長凸顯了改進診斷工具的迫切需求。由於癌症治療的進步，組織診斷的複雜性不斷增加，需要世界各地實驗室改進技術和能力。提高本地診斷能力對於管理全球癌症發病率的預測成長至關重要，因為它可以縮短測試週轉時間並提高診斷準確性。

組織診斷產業的分析前染色市場由幾個關鍵因素推動，包括染色技術的進步、簡化次世代定序前平台、自動化染色平台以及提高效率和重現性的高通量系統。組織診斷領域的參與者越來越注重開發創新和先進的系統和染色劑，以提高組織診斷的特異性和敏感性。特別是，這是由於對 ISH 和 IHC 的需求增加、將 CDx 作為病理測試一部分的強制性法規，以及生物製藥公司和診斷藥物公司之間合作的加強。

亞太地區癌症診斷基礎設施的成長、癌症發生率的增加、醫療保健支出的增加、先進診斷技術的普及以及政府支持的擴大，都使該地區成為成長最快的市場。

成長指標
生長促進因子
成長抑制因素
組織診斷產業的趨勢
預測方法和假設
收益和預測
收益和預測分析
按技術分類的收益預測
主要成長機會 - 組織診斷領域
地區收益預測
區域收益分析-NA
組織診斷市場動態-NA
區域收益分析 - 歐洲
組織診斷市場動態- 歐洲
區域收益分析 - 亞太地區
組織診斷的市場動態- 亞太地區
區域收益分析 - MENASA 和拉丁美洲
最終用戶的收益預測
最終用戶收益分析
收益佔有率
收益佔有率分析
競賽矩陣
全球組織診斷市場－值得注意的活動
組織診斷的商業機會與創新藍圖

生長機會分析：分析前染色中的生長發生器

生長指示劑-預處理染色
分析前染色收益預測
預分析染色收益預測分析
預分析染色收益預測分析

生長機會分析：高級染色中的生長發生器

生長指標-高階染色
先進染色收益預測
進階染色 -收益預測分析
FDA核准的基於組織的伴隨診斷清單，2022-2023 年

成長機會分析：ICP-APLIS 成長產生器

生長指標-ICP-APLIS
ICP-APLIS收益預測
ICP-APLIS-收益預測分析
ICP-APLIS-收益預測分析

存取控制解決方案的成長機會領域

成長機會 1 - 用於早期識別癌症生物標記的綜合診斷組合
成長機會2－多組體學分析實現精準診斷
成長機會 3 - 用於基於組織的伴同性診斷的數位病理學功能

最佳實踐認證

最佳實踐評估

FROST RADAR

FROST RADAR

下一步

成長機會的好處和影響
下一步
圖表列表
免責聲明

簡介目錄

Product Code: PFLA-55

Companion Diagnostics-specific Advanced Staining and Multiomics Capabilities are Driving Market Growth

The global tissue diagnostics market will experience significant growth driven by the need for advanced staining in precise biomarker identification in personalized medicine, tissue biopsy test volumes, and pre-analytical and advanced staining platform development.

According to the WHO, there will be a 60% rise in cancer cases worldwide by 2040, which will fuel demand for tissue diagnostics. This increase highlights how urgently improved diagnostic tools are needed. The complexity of tissue diagnostics expanded due to advancements in cancer treatment, which require enhanced technology and capabilities in laboratories across the globe. Improving local diagnostic capacity is vital for managing the projected growth in cancer incidence worldwide, as it can improve test turnaround times and diagnostic accuracy-both of which substantially impact cancer treatment outcomes.

The pre-analytical staining market in the tissue diagnostics industry is being propelled by several key factors, such as growing advancements in staining technologies, pre-analytical platforms to simplify next-generation sequencing, automated staining platforms, and high-throughput systems to drive efficiency and reproducibility. Tissue diagnostics players are increasingly focusing on developing innovative and advanced systems and stains that enhance the specificity and sensitivity of tissue diagnostics. The advanced staining segment is the second leading segment due to a surge in adoption, especially driven by increased demand for ISH and IHC offerings, regulatory mandates to include CDx as part of pathology tests, and increased partnerships between biopharma companies and diagnostic companies.

Asia-Pacific's growing cancer diagnostics infrastructure, increasing cancer prevalence rate, rising healthcare spending, increasing access to advanced diagnostic technologies, and growing government support all contribute to the region being the fastest-growing market.

Transformation in Global Tissue Diagnostics Industry

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Global Tissue Diagnostic Industry

Growth Environment-Ecosystem in Tissue Diagnostics Industry

Scope of Analysis
Segmentation

Growth Environment-Companies to Action

Competitive Environment
Key Competitor by Technology

Growth Opportunity Analysis-Growth Generator in Tissue Diagnostics Industry

Growth Metrics
Growth Drivers
Growth Restraints
Trends in the Tissue Diagnostics Industry
Forecast Methodology and Assumptions
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Technology
Primary Growth Opportunities-Tissue Diagnostics Segments
Revenue Forecast by Region
Revenue Forecast Analysis by Region-NA
Tissue Diagnostics Market Dynamics-NA
Revenue Forecast Analysis by Region-Europe
Tissue Diagnostics Market Dynamics-Europe
Revenue Forecast Analysis by Region-APAC
Tissue Diagnostics Market Dynamics-APAC
Revenue Forecast Analysis by Region-MENASA & Latin America
Revenue Forecast by End User
Revenue Forecast Analysis by End User
Revenue Share
Revenue Share Analysis
Competitor Matrix
Global Tissue Diagnostics Market-Notable Activities
Tissue Diagnostics Opportunity and Innovations Roadmap

Growth Opportunity Analysis-Growth Generator in Pre-Analytical Staining

Growth Metrics-Pre-Analytical Staining
Pre-analytical Staining Revenue Forecast
Pre-analytical Staining Revenue Forecast Analysis
Pre-analytical Staining Revenue Forecast Analysis

Growth Opportunity Analysis-Growth Generator in Advanced Staining

Growth Metrics-Advance Staining
Advanced Staining Revenue Forecast
Advanced Staining-Revenue Forecast Analysis
List of FDA-approved Tissue-based CDx, 2022-2023

Growth Opportunity Analysis-Growth Generator in ICP-APLIS

Growth Metrics-ICP-APLIS
ICP-APLIS Revenue Forecast
ICP-APLIS-Revenue Forecast Analysis
ICP-APLIS-Revenue Forecast Analysis

Growth Opportunity Universe in Access Control Solutions

Growth Opportunity 1-Comprehensive Diagnostic Panels for Early Identification Of Cancer Biomarkers
Growth Opportunity 2-Multiomics Analysis for Precision Diagnostics
Growth Opportunity 3-Digital Pathology Capabilities for Tissue-based Companion Diagnostics